These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 17383496

  • 1. Type-D personality exerts a stable, adverse effect on vital exhaustion in PCI patients treated with paclitaxel-eluting stents.
    Pedersen SS, Daemen J, van de Sande M, Sonnenschein K, Serruys PW, Erdman RA, van Domburg RT.
    J Psychosom Res; 2007 Apr; 62(4):447-53. PubMed ID: 17383496
    [Abstract] [Full Text] [Related]

  • 2. Type-D personality and depressive symptoms predict anxiety 12 months post-percutaneous coronary intervention.
    van Gestel YR, Pedersen SS, van de Sande M, de Jaegere PP, Serruys PW, Erdman RA, van Domburg RT.
    J Affect Disord; 2007 Nov; 103(1-3):197-203. PubMed ID: 17346801
    [Abstract] [Full Text] [Related]

  • 3. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents.
    Pedersen SS, Denollet J, Daemen J, van de Sande M, de Jaegere PT, Serruys PW, Erdman RA, van Domburg RT.
    J Psychosom Res; 2007 Apr; 62(4):455-61. PubMed ID: 17383497
    [Abstract] [Full Text] [Related]

  • 4. Type-D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era.
    Spindler H, Pedersen SS, Serruys PW, Erdman RA, van Domburg RT.
    J Affect Disord; 2007 Apr; 99(1-3):173-9. PubMed ID: 17049996
    [Abstract] [Full Text] [Related]

  • 5. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS, Denollet J, Ong AT, Sonnenschein K, Erdman RA, Serruys PW, van Domburg RT.
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
    [Abstract] [Full Text] [Related]

  • 6. Impaired health status in Type D patients following PCI in the drug-eluting stent era.
    Pedersen SS, Denollet J, Ong AT, Serruys PW, Erdman RA, van Domburg RT.
    Int J Cardiol; 2007 Jan 18; 114(3):358-65. PubMed ID: 16753232
    [Abstract] [Full Text] [Related]

  • 7. Type D personality and diabetes predict the onset of depressive symptoms in patients after percutaneous coronary intervention.
    Pedersen SS, Ong AT, Sonnenschein K, Serruys PW, Erdman RA, van Domburg RT.
    Am Heart J; 2006 Feb 18; 151(2):367.e1-367.e6. PubMed ID: 16442900
    [Abstract] [Full Text] [Related]

  • 8. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy.
    Pedersen SS, Lemos PA, van Vooren PR, Liu TK, Daemen J, Erdman RA, Smits PC, Serruys PW, van Domburg RT.
    J Am Coll Cardiol; 2004 Sep 01; 44(5):997-1001. PubMed ID: 15337209
    [Abstract] [Full Text] [Related]

  • 9. Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention.
    Pedersen SS, Denollet J, van Gestel YR, Serruys PW, van Domburg RT.
    Eur J Cardiovasc Prev Rehabil; 2008 Apr 01; 15(2):203-9. PubMed ID: 18391649
    [Abstract] [Full Text] [Related]

  • 10. Course of anxiety symptoms over an 18-month period in exhausted patients post percutaneous coronary intervention.
    Pedersen SS, Smith OR, De Vries J, Appels A, Denollet J.
    Psychosom Med; 2008 Apr 01; 70(3):349-55. PubMed ID: 18378871
    [Abstract] [Full Text] [Related]

  • 11. Effects of a behavioural intervention on quality of life and related variables in angioplasty patients: results of the EXhaustion Intervention Trial.
    Appels A, van Elderen T, Bär F, van der Pol G, Erdman RA, Assman M, Trijsburg W, van Diest R, van Dixhoorn J, Pedersen SS.
    J Psychosom Res; 2006 Jul 01; 61(1):1-7; discussion 9-10. PubMed ID: 16813838
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ, Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators.
    Circulation; 2008 Aug 05; 118(6):632-8. PubMed ID: 18645057
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for impaired health status differ in women and men treated with percutaneous coronary intervention in the drug-eluting stent era.
    Pedersen SS, Ong AT, Lemos PA, Erdman RA, Serruys PW, van Domburg RT.
    J Psychosom Res; 2006 Jul 05; 61(1):11-7. PubMed ID: 16813840
    [Abstract] [Full Text] [Related]

  • 14. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR, Rao A, Asghar O, Ramsdale KA, McKay E.
    J Invasive Cardiol; 2008 Oct 05; 20(10):493-500. PubMed ID: 18829991
    [Abstract] [Full Text] [Related]

  • 15. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA, Andrianopoulos N, Duffy S, Walton AS, Clark D, Lew R, Sebastian M, New G, Brennan A, Reid C, Ajani AE, Melbourne Interventional Group.
    Cardiovasc Revasc Med; 2008 Oct 05; 9(4):218-23. PubMed ID: 18928945
    [Abstract] [Full Text] [Related]

  • 16. Predictors of quality-of-life benefit after percutaneous coronary intervention.
    Spertus JA, Salisbury AC, Jones PG, Conaway DG, Thompson RC.
    Circulation; 2004 Dec 21; 110(25):3789-94. PubMed ID: 15596563
    [Abstract] [Full Text] [Related]

  • 17. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention.
    Pedersen SS, Denollet J, Spindler H, Ong AT, Serruys PW, Erdman RA, van Domburg RT.
    J Psychosom Res; 2006 Dec 21; 61(6):783-9. PubMed ID: 17141666
    [Abstract] [Full Text] [Related]

  • 18. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.
    Thromb Res; 2009 May 21; 124(1):46-51. PubMed ID: 19041120
    [Abstract] [Full Text] [Related]

  • 19. The impact of Type D personality on health-related quality of life in tinnitus patients is mainly mediated by anxiety and depression.
    Bartels H, Pedersen SS, van der Laan BF, Staal MJ, Albers FW, Middel B.
    Otol Neurotol; 2010 Jan 21; 31(1):11-8. PubMed ID: 19816233
    [Abstract] [Full Text] [Related]

  • 20. Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.
    Liu HB, Xu B, Yang YJ, Wang Y, Qin XW, Yao M, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Ma WH, Li JJ, Qiao SB, Chen JL, Li W, Gao RL.
    Chin Med J (Engl); 2009 Mar 20; 122(6):681-6. PubMed ID: 19323934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.